Mtor inhibition as a novel gene therapeutic strategy for diabetic retinopathy

HIGHLIGHTS

• who: Steven Hyun Seung Lee and colleagues from the CdmoGen Co, Ltd, Cheongju, Department of Ophthalmology, Asan Medical Center, University have published the research work: mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy, in the Journal: PLOS ONE of May/31,/2022
• what: Having previously demonstrated the potential of a mTOR-inhibiting shRNA packaged in a recombinant adenoassociated virus to address a variety of angiogenic retinal diseases here the authors explore the effects of rAAV2-shmTOR-SD in a streptozotocin-induced diabetic mouse model.
• how: Next the authors examined in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.